Member Info for PhilGekko

@johnht - Thanks John, at 79% efficacy (despite low patient sample and potential drop on a larger sample) it is still a Covid blockbuster so potentially very lucrative. Popcorn ready!

Sure, COPD market in its own right is absolutely enormous, and there is a significant unmet need - I was amazed that market did not react more favourably to the RNS last week and the confirmation that it is showing efficacy in tandem with steroid treatment (if I remember correctly).

Even if it hits 150p I don't care if it is temporary market panic but fundamentals are still there and things are progressing.
Fingers crossed... good luck!

Agreed, serious respiratory care expertise and brain firepower on board - even without Covid happening SNG would be a strong COPD treatment which is a huge market

Thanks CaptMinty - appreciated. I am not a day trader so rarely get wound up if share is fluctuating due to temp. market forces - if I believe in the fundamentals/potential and the team behind the stock I just ride it out. I am still holding and quite far from the stage where I am thinking of selling but like to pick people's brains when something doesn't quite add up... Good luck and thanks again

Ladies and gentlemen - I have been following this forum for a while but this is my first post as genuinely interested in views of people who've been holding a position in SNG for a while... I have a position and hoping SNG comes through so wanted to ask whether anyone has any info re next steps.. i.e. timelines

1.Do we have any clarity which agencies/regulatory bodies we are in discussions with? I couldn't find anything on EMA website, doesn't appear like we're being evaluated
2. Do we have any timelines on announcements from SNG re next steps? We were all looking forward to some news before the end of summer - interim COPD results RNS last week didn't exactly do wonders and not sure when we are expecting to hear feedback re Covid trials? I have been investing in biotech for a while and know that good things come to those who wait, would just like to know what we're waiting for.
3. How is it that we are not hearing anything more concrete from the government re SNG progress/investment? Even if efficacy drops from 79% to 40% it is still a huge in-licensing opportunity for big pharma and essentially a blockbuster - why is there no more hype around it? There are new treatments being tested and sent for approval left right and centre... we're losing momentum and potentially first mover advantage for any impending licensing talks

I hold a substantial position in SNG, and success of SNG001 would be huge for me so really not looking for any arguments and/or pointless bickering - interested in views of people who are in the same boat as me. Thanks everyone!